{
    "nctId": "NCT02858804",
    "officialTitle": "EDOCH Alternating With DHAP Regimen Combined Rituximab or Not to Treat New Diagnosed Younger (Age\u226465 Years) Mantle Cell Lymphoma in China: A Multicentre Phase III Trial",
    "inclusionCriteria": "* age\u226465 years\n* diagnosis with mantle cell lymphoma\n* Ann Arbor stage II,III or IV\n* ECOG\u22641 or if ECOG\u22652 but recover after pretreatment.\n* Must have minimum age of 18 Years\n* Must have maximum age of 65 Years",
    "exclusionCriteria": "* with centre neural system involvement\n* serious complications such as uncontrolled diabetes, gastric ulcer or other serious angiocardiopathy determined by the physician\n* HIV positive or active HBV infection or other uncontrolled systematic infection\n* clinical central nervous dysfunction\n* serious surgery within 30 days\n* pregnancy or baby nursing period or un-contracepted child bearing period woman."
}